Simvastatin Fails to Slow Parkinson’s Progression, Trial Data Shows
Sep 24, 2020 07:00 am | Joana Carvalho, PhD
Simvastatin, a widely-used cholesterol-lowering medication, failed to slow the progression of Parkinson’s disease, according to data from a Phase 2 trial. Based on these findings, it was decided that a future Phase 3 study assessing the safety and efficacy of simvastatin in these patients would not be justified. Data from the study, called PD-STAT (NCT02787590), […]
The post Simvastatin Fails to Slow Parkinson’s Progression, Trial Data Shows appeared first on Parkinson's News Today.